Immunological and pharmacological heterogeneity of α-bungarotoxin binding sites extracted from TE671 cells
- 1 August 1988
- journal article
- research article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 19 (1-2) , 149-157
- https://doi.org/10.1016/0165-5728(88)90044-6
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Plasma from myasthenia gravis patients reduces acetylcholine receptor agonist-induced Na+ flux into TE671 cell lineJournal of Neuroimmunology, 1988
- Epitopes on Human Acetylcholine Receptor Defined by Monoclonal Antibodies and Myasthenia Gravis SeraAutoimmunity, 1988
- Using Monoclonal Antibodies to Determine the Structures of Acetylcholine Receptors from Electric Organs, Muscles, and NeuronsaAnnals of the New York Academy of Sciences, 1987
- Characterization of Curaremimetic Neurotoxin Binding Sites on Membrane Fractions Derived from the Human Medulloblastoma Clonal Line, TE671Journal of Neurochemistry, 1986
- Monoclonal antibodies that distinguish between normal and denervated human acetylcholine re receptorJournal of Neuroimmunology, 1986
- Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays.Journal of Neurology, Neurosurgery & Psychiatry, 1985
- Assembly in vivo of mouse muscle acetylcholine receptor: Identification of an α subunit species that may be an assembly intermediateCell, 1983
- Neuronal-like features of TE671 cells: Presence of a functional nicotinic cholinergic receptorBrain Research, 1982
- Establishment of a human medulloblastoma cell lineInternational Journal of Cancer, 1977
- An assay for antibodies to human acetylcholine receptor in serum from patients with myasthenia gravisClinical Immunology and Immunopathology, 1977